E-liquid alters oral epithelial cell function to promote epithelial to mesenchymal transition and invasiveness in preclinical oral squamous cell carcinoma.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
de Lima (2023)
Genotoxicity risk assessment: a proposed classification strategy
Policy
EPa
Chemical Risk Assessment Guidelines
Dearfield (2002)
Subjective experiences, contexts, and risk perceptions of very low nicotine content cigarettes and electronic cigarettes among people with depression and anxiety disorders who smoke.
Population Clinical
Perception Of Risk
Comparison With Tobacco And Other Nicotine Products
DeAtley (2023)
Effect of Electronic Cigarettes on the Gastrointestinal System.
Individual Clinical
Safety
Adverse Effects
Debnath (2022)
e-Cigarette and Cigarette Use among Youth: Gateway or Common Liability?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Delnevo (2023)
acute effects of electronic cigarette smoking on ventricular repolarization in adults.
Individual Clinical
Safety
Relative Health Effects Of User
Demir (2020)
Reactions to using other nicotine and tobacco products instead of menthol cigarettes: A qualitative study of people who smoke menthol cigarettes in the United States.
Population Clinical
Cessation
Tobacco
Denlinger-Apte (2023)
Electronic cigarette use among adults with asthma: 2014-2017 National Health Interview Survey.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Deshpande (2020)
E-cigarette nicotine dose and flavor: Relationship with appeal, choice, and tobacco use amongst veterans with comorbid psychiatric disorders.
Population Clinical
Consumer Use
Reasons For Use
DeVito (2019)
Electronic Nicotine Delivery Systems (ENDS) Use and Pregnancy II: Perinatal Outcomes Following ENDS Use During Pregnancy.
Nonclinical
Reproductive & Developmental Effects
In Vivo
DeVito (2021)